Michael Schrag

Hematopoietic Progenitors and Aging: Alterations in Granulocytic Precursors and Responsiveness to Recombinant Human G-CSF, GM-CSF, and IL-3

Gurkamal Chatta, R. G. Andrews, Elin Rodger et al. · Journal of Gerontology · 1993 · 140 citations

Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors

Noel D. D’Angelo, Tae‐Seong Kim, Kristin L. Andrews et al. · Journal of Medicinal Chemistry · 2011 · 118 citations · Full text

Drug Target, Pharmacotherapy, Benzothiazole Phosphoinositide 3-Kinase +21

MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR

Ping Lü, Michael Schrag, Donald E. Slaughter et al. · Drug Metabolism and Disposition · 2003 · 105 citations

A Refined 3-Dimensional QSAR of Cytochrome P450 2C9:  Computational Predictions of Drug Interactions

Sreedhara V. Rao, Ron Aoyama, Michael Schrag et al. · Journal of Medicinal Chemistry · 2000 · 91 citations · Full text

Pyrene·Pyrene Complexes at the Active Site of Cytochrome P450 3A4:  Evidence for a Multiple Substrate Binding Site

Michael J. Dabrowski, Michael Schrag, Larry C. Wienkers et al. · Journal of the American Chemical Society · 2002 · 90 citations

Molecular Biology, Pyrene·pyrene Complexes, Chemical Biology +18